T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1276
Telecom Argentina
TEO
$5.81B
| $14.2M | ﹤0.01% |
388,043
+155,448
| +67% | +$5.34M |
|
|
TWNK
1277
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $14.1M | ﹤0.01% |
951,117
+400,892
| +73% | +$5.28M |
|
1278
F5
FFIV
$24B
| $14M | ﹤0.01% |
106,757
-50,227
| -32% | -$6.24M |
|
1279
International Seaways
INSW
$4.58B
| $13.8M | ﹤0.01% |
745,382
-27,600
| -4% | -$517K |
|
1280
Wayfair
W
$13.9B
| $13.7M | ﹤0.01% |
170,631
+708
| +0.4% | +$49.7K |
|
1281
Chipotle Mexican Grill
CMG
$41.3B
| $13.7M | ﹤0.01% |
2,366,300
-5,861,450
| -71% | -$35M |
|
1282
Barings BDC
BBDC
$987M
| $13.5M | ﹤0.01% |
1,423,427
+390,330
| +38% | +$4.28M |
|
1283
Advance Auto Parts
AAP
$3.23B
| $13.5M | ﹤0.01% |
135,341
+2,400
| +2% | +$221K |
|
1284
IPG Photonics
IPGP
$3.71B
| $13.4M | ﹤0.01% |
62,792
-13,720
| -18% | -$2.91M |
|
|
BEAT
1285
DELISTED
BioTelemetry, Inc.
BEAT
| $13.3M | ﹤0.01% |
446,255
+4,427
| +1% | +$128K |
|
1286
ManpowerGroup
MAN
$2.61B
| $13.3M | ﹤0.01% |
105,448
-4,093
| -4% | -$511K |
|
1287
Donaldson
DCI
$11.1B
| $13.1M | ﹤0.01% |
267,852
-591
| -0.2% | -$28.2K |
|
|
AIV
1288
Aimco
AIV
$379M
| $13.1M | ﹤0.01% |
2,249,211
+27,400
| +1% | +$161K |
|
1289
Goodyear
GT
$1.78B
| $13.1M | ﹤0.01% |
404,594
-53,800
| -12% | -$1.71M |
|
|
LUMO
1290
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $13M | ﹤0.01% |
177,804
+35,068
| +25% | +$2.9M |
|
|
SIOX
1291
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
| $12.8M | ﹤0.01% |
304,577
+58,147
| +24% | +$2.61M |
|
1292
MGE Energy Inc
MGEE
$3.06B
| $12.7M | ﹤0.01% |
201,672
+72,313
| +56% | +$4.7M |
|
|
IMGN
1293
DELISTED
Immunogen Inc
IMGN
| $12.7M | ﹤0.01% |
1,975,716
+1,040,580
| +111% | +$6.42M |
|
1294
FS Bancorp
FSBW
$325M
| $12.6M | ﹤0.01% |
462,786
-17,192
| -4% | -$473K |
|
|
SFLY
1295
DELISTED
Shutterfly, Inc.
SFLY
| $12.6M | ﹤0.01% |
253,487
-347
| -0.1% | -$15.7K |
|
|
ESPR
1296
DELISTED
Esperion Therapeutics
ESPR
| $12.5M | ﹤0.01% |
190,087
+111,723
| +143% | +$6.02M |
|
|
ALDR
1297
DELISTED
Alder Biopharmaceuticals
ALDR
| $12.4M | ﹤0.01% |
1,079,279
+126,000
| +13% | +$1.41M |
|
1298
Ranger Energy Services
RNGR
$405M
| $12.3M | ﹤0.01% |
1,335,240
-15,660
| -1% | -$173K |
|
1299
AES
AES
$10.5B
| $12.2M | ﹤0.01% |
1,129,696
+129,100
| +13% | +$1.4M |
|
1300
CorVel
CRVL
$3.17B
| $12.2M | ﹤0.01% |
692,679
-23,688
| -3% | -$446K |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.